The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover
- 30 June 1993
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 101 (1) , 61-68
- https://doi.org/10.1016/0021-9150(93)90102-z
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Lipoprotein(a) in cirrhosis.BMJ, 1992
- Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroidAtherosclerosis, 1992
- Lipid and lipoprotein (a) concentrations in renal ransplant patientsNephrology Dialysis Transplantation, 1992
- Lipoprotein(a) and AtherosclerosisAnnals of Internal Medicine, 1991
- Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.Journal of Clinical Investigation, 1991
- Catabolism of lipoprotein(a) in familial hypercholesterolaemic subjectsAtherosclerosis, 1991
- Genetics of the quantitative Lp(a) lipoprotein traitHuman Genetics, 1989
- The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levelsAtherosclerosis, 1986
- Levels of lipoprotein Lp(a) decline with neomycin and niacin treatmentAtherosclerosis, 1985
- Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozololBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984